Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia
Clinical trial NCT04461119 · COMPLETED
Trial details
- NCT number
- NCT04461119
- Sponsor
- Newron Pharmaceuticals SPA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-16
- Primary completion
- 2021-02-20
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.